XPOT and leukemia: While several studies have revealed XPOT overexpression in mesothelioma, leukemia HL-60 cells, and hepatocellular carcinoma 20-23, the exact molecular mechanisms of XPOT in these tumors remain elusive, especially whether and how XPOT modulates tumor progression through tRNA nuclear export.